Marmé, F. (2016). Phase 1 study of sorafenib and eribulin in patients with advanced, metastatic or refractory solid tumors. Annals of oncology, 27, . https://doi.org/10.1093/annonc/mdw368.40
Chicago-Zitierstil (17. Ausg.)Marmé, Frederik. "Phase 1 Study of Sorafenib and Eribulin in Patients with Advanced, Metastatic or Refractory Solid Tumors." Annals of Oncology 27 (2016). https://doi.org/10.1093/annonc/mdw368.40.
MLA-Zitierstil (9. Ausg.)Marmé, Frederik. "Phase 1 Study of Sorafenib and Eribulin in Patients with Advanced, Metastatic or Refractory Solid Tumors." Annals of Oncology, vol. 27, 2016, https://doi.org/10.1093/annonc/mdw368.40.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.